Revenue increased 13.7%
Revenue changed +13.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +13.7% from the comparable as-filed period.
Operating margin changed -121 basis points from the comparable as-filed period.
Net income changed -21.4% from the comparable as-filed period.
Gross margin changed +145 basis points from the comparable as-filed period.
Debt / equity changed +1035 basis points from the comparable as-filed period.
Debt / revenue changed -1727 basis points from the comparable as-filed period.
Research & development changed +22.2% from the comparable as-filed period.
Cash / debt changed -2572 basis points from the comparable as-filed period.
Working capital / assets changed -498 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +16.0% from the comparable as-filed period.
Operating income changed +6.9% from the comparable as-filed period.
Trade receivables changed +20.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +17.7% from the comparable as-filed period.
Current assets changed -11.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current liabilities changed +5.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +1.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed -2.9% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Stockholders' equity changed -6.5% from the comparable as-filed period.
Capex / revenue changed -72 basis points from the comparable as-filed period.
Cost of revenue changed +8.0% from the comparable as-filed period.
Current ratio changed -15.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed +113 basis points from the comparable as-filed period.
Gross debt changed +2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Reported total debt changed +2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed -3.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +18 basis points from the comparable as-filed period.
Debt / assets changed +39 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +26 basis points from the comparable as-filed period.
Revenue changed +14.8% from the comparable as-filed period.
Gross margin changed +188 basis points from the comparable as-filed period.
Current long-term debt changed -27.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +221 basis points from the comparable as-filed period.
Debt / equity changed +490 basis points from the comparable as-filed period.
Debt / revenue changed -1915 basis points from the comparable as-filed period.
Gross profit changed +17.8% from the comparable as-filed period.
Capital expenditure changed +66.4% from the comparable as-filed period.
Cash / debt changed +354 basis points from the comparable as-filed period.
Research & development changed +15.0% from the comparable as-filed period.
Cash & equivalents changed +11.6% from the comparable as-filed period.
Shares outstanding changed -2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Current assets changed +1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Cost of revenue changed +7.2% from the comparable as-filed period.
Receivables / revenue changed +99 basis points from the comparable as-filed period.
Stock-based compensation changed +10.3% from the comparable as-filed period.
Debt / assets changed +82 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed +2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Reported total debt changed +2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -24 basis points from the comparable as-filed period.
Stockholders' equity changed -1.8% from the comparable as-filed period.
Current liabilities changed -0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +74 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net debt changed -3.4% from the comparable as-filed period.
Total assets changed -0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +2 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.